Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Predictors of Healthy Mood and Memory After Oophorectomy

Trial Profile

Predictors of Healthy Mood and Memory After Oophorectomy

Status: Withdrawn prior to enrolment
Phase of Trial: Phase IV

Latest Information Update: 29 Mar 2017

Price : $35 *
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Estradiol (Primary) ; Lisdexamfetamine (Primary)
  • Indications Cognition disorders; Memory disorders; Mood disorders
  • Focus Pharmacodynamics
  • Acronyms E2-LDX
  • Most Recent Events

    • 21 Mar 2017 Status changed from active, no longer recruiting to withdrawn prior to enrolment because Funding was not obtained for this study and no participants were enrolled. .
    • 12 Oct 2016 Planned End Date changed from 1 Jul 2015 to 1 Jun 2020.
    • 12 Oct 2016 Planned primary completion date changed from 1 Jul 2015 to 1 Jun 2020.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top